The largest database of trusted experimental protocols

Collagenase treatment

Manufactured by Merck Group
Sourced in Italy

Collagenase treatment is a laboratory reagent used to break down collagen, a structural protein found in various tissues. It is commonly used in cell culture and tissue engineering applications to facilitate the isolation and dissociation of cells from their extracellular matrix.

Automatically generated - may contain errors

2 protocols using collagenase treatment

1

Isolation and Characterization of Primary HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Umbilical cords were collected and stored at 4 °C and processed within 24 of collection. Primary female HUVECs (FHUVECs) and male HUVEC (MHUVECs) were isolated by collagenase treatment (Sigma-Aldrich, Milano, Italy), as previously described by Addis et al. [25 (link)] and cultured in plates pre-coated with 1% gelatine (Sigma-Aldrich, Milano, Italy) in an M199 medium (Life Technologies, Monza, Italy) supplemented with 10% fetal bovine serum (FBS) (Life Technologies, Monza, Italy), 10% newborn calf serum (NBCS) (Life Technologies, Monza, Italy), 1% antibiotic/antimycotic (Sigma-Aldrich, Milano, Italy) and 2 mM of L-glutamine (Sigma-Aldrich, Milano, Italy), until confluence, in a 5% CO2 humidified atmosphere. As previously described (Addis), cultured cells were characterized as endothelial cells by the exhibition of cobblestone morphology when they were contact-inhibited and by an evaluation of the expression of von Willebrand factor, a glycoprotein that is constitutively stored in intra-endothelial Weibel–Palade granules.
FHUVECs and MHUVECs were used in passage 3 to ensure their endothelial characteristics, and all experiments were conducted in duplicate or triplicate.
+ Open protocol
+ Expand
2

Isolation and Characterization of Primary HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Umbilical cords were collected and stored at 4 °C and processed within 24 of collection. Primary female HUVECs (FHUVECs) and male HUVEC (MHUVECs) were isolated by collagenase treatment (Sigma-Aldrich, Milano, Italy), as previously described by Addis et al. [25 (link)] and cultured in plates pre-coated with 1% gelatine (Sigma-Aldrich, Milano, Italy) in an M199 medium (Life Technologies, Monza, Italy) supplemented with 10% fetal bovine serum (FBS) (Life Technologies, Monza, Italy), 10% newborn calf serum (NBCS) (Life Technologies, Monza, Italy), 1% antibiotic/antimycotic (Sigma-Aldrich, Milano, Italy) and 2 mM of L-glutamine (Sigma-Aldrich, Milano, Italy), until confluence, in a 5% CO2 humidified atmosphere. As previously described (Addis), cultured cells were characterized as endothelial cells by the exhibition of cobblestone morphology when they were contact-inhibited and by an evaluation of the expression of von Willebrand factor, a glycoprotein that is constitutively stored in intra-endothelial Weibel–Palade granules.
FHUVECs and MHUVECs were used in passage 3 to ensure their endothelial characteristics, and all experiments were conducted in duplicate or triplicate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!